News

CEO Christophe Weber to retire from Takeda in June 2026 after 12 years; Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession process ...
Weber, who joined Takeda in 2014 and became CEO the following year, is one of the longest-tenured CEOs in the pharmaceutical industry. He arrived at Takeda after more than 21 years at GSK in ...
Christophe Weber will step down as CEO of Takeda next year, the company announced Thursday, following a drop-off in its share price over the last couple of years.
Takeda has named Julie Kim as its next CEO. She will replace Christophe Weber who plans to step down in June of 2026 after leading Japan’s largest drugmaker for 11 years.
Earnings Call Insights: Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2025 Christophe Weber, CEO, announced his ...
Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old Japanese drugmaker.
Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, emerging as one of the world's leading pharmaceutical companies.
CEO Christophe Weber to retire from Takeda in June 2026 after 12 years. Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession process.
Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S. business unit. As part of the executive transition, Weber will retire in June ...
“The Board of Directors has unanimously chosen Julie Kim to lead Takeda into the next chapter, building on the company’s success under Christophe Weber’s remarkable leadership,” said Masami Iijima, ...
Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top drugmaker.
EQS-Adhoc Takeda Pharmaceutical Company Limited: Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026 30.01.2025, 09:31 Uhr von EQS News Jetzt kommentieren: 0 30.01.2025, 09:31 ...